In addition, the possible association between this marker and more types of cancer need to be examined, especially for ovary tumor and neuroblastoma, where abnormal ZFPM2 expression has been reported, in order to determine the extent of specificity of the rs71305152-glioma association. This evidence concerns the gene ZFPM2 and cancer.